The Global Veterinary Artificial Insemination market is anticipated to reach USD 5.94 billion by 2027, according to a new report by Reports and Data. The Artificial Insemination Market (AI) is expected to see a rise in demand due to increased animal protein consumption and increased demand for high cattle productivity & milk yields. Market players are introducing artificial insemination to meet the ever-increasing demand to breed high-quality livestock and increase efficiency. Demand has increased over the years, owing to the growing prevalence of various animal diseases, such as zoonotic diseases, and the increasing adoption of animals that follow them.
According to the 2019 publication of the Food and Agriculture Organization (FAO), livestock accounted for approximately 40 % of the global value of agricultural production in developed countries and 20% in developing countries, providing food security and livelihood for more than 1.3 billion people worldwide. Favorable government regulations aimed at increasing productivity often contribute to growth; for example, in 2018 the Indian government authorized an Agriculture Export Policy to boost the nation’s agricultural economic growth. The new strategy aims to raise India’s agricultural production to USD 60 billion by 2022 and USD 100 billion in the next few years with a stable foreign-policy system.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3476
The industry meets the guidelines set by the International Artificial Insemination Society (ISAG) and leading laboratories for animal science, such as Davis University of California (U.C. Davis). The standard ISAG panel consists of 18 STR markers, and every artificial insemination business needs to adopt the panel and norm set by the authority. Nevertheless, increasing populations are expected to pose a continuous challenge to food supply and animal protein requirement, boosting demand development.
Further key findings from the report suggest:
- Given the rising consumption of milk and its products in Asian countries, the cattle segment was the largest revenue-generating segment in 2019.
- The usual semen segment represented the largest share of revenue in the drug category in 2019, due to the low cost of the procedure.
- The animal husbandry accounts for the largest share in the end-user segment and is expected to retain its predominance over the forecast period. The increase can be attributed to the maximum number of procedures for collecting semen conducted under such facilities.
- Use of sexed semen is expected to display the highest growth over the forecast period.
- Asia Pacific was the region’s leading sector and accounts for the largest share of revenue in 2019 mainly due to the region’s high cattle population.
- In May 2019, Genus plc partnered with the China based Beijing Capital Agribusiness (BCA). BCA is intended to help the organization grow reproductive and respiratory syndrome virus (PrRVS)–resistant animals in proprietary technology applications.
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/3476
Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in the healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register the highest market growth over the forecast period attributed to the increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.
The growing popularity of over-the-counter medications driving market growth
Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.
Restriction on product launches and R&D activities to hamper the market growth
The imposition of strict government regulations and shortage of funds has put a halt on product launches and R&D activities and is expected to restrain market growth over the forecast period. In addition, the launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering the market growth.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, mergers and acquisitions, collaborations, and joint ventures to gain a robust footing in the market.
Top Companies Profiled in the Report:
Sires, Inc., Swine Genetics International, SEMEX, Zoetis, Cooperative Resource International (GENEX), Cogent, Viking Genetics, Genus plc, Polar Genetics India, and Fox Fire Farm, among others.
Veterinary Artificial Insemination Market Segmentation:
Product Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
- Normal Semen
- Sexed Semen
Animal Type Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
- Cattle
- Swine
- Sheep
- Canine
- Equine
- Others
End-Use Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
- Veterinary Hospitals
- Animal Husbandry
- Others
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)
Frequently asked questions addressed in the report:
- What is the revenue growth rate of the global Veterinary Artificial Insemination market over the forecast period?
- What are the major factors driving the growth of the Global Veterinary Artificial Insemination Market?
- What are the key challenges impacting the global Veterinary Artificial Insemination market growth?
- What are the outcomes of the SWOT Analysis and Porter’s Five Forces Analysis conducted in the report?
Request customization on the report @ https://www.reportsanddata.com/request-customization-form/3476
Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.
Explore Latest Trending Research Reports By Reports and Data:
Acute Respiratory Distress Syndrome (ARDS) Market @ https://www.biospace.com/article/acute-respiratory-distress-syndrome-ards-market-growth-report-size-share-and-rising-demand-till-2027/
3D Bioprinting Market @ https://www.biospace.com/article/3d-bioprinting-market-size-worth-usd-2-687-8-million-by-2027-emergen-research/
Spine Therapy Market @ https://www.biospace.com/article/spine-therapy-market-emerging-trends-demand-growth-by-key-players-and-forecast-2027/
Spine Biologics Market @ https://www.biospace.com/article/spine-biologics-market-research-by-type-applications-key-players-region-and-forecast-2027/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/videos